A Common Blood Test Identifies Which COVID-19 Patients Benefit and Which Are Harmed from Steroid Treatment

July 22, 2020—(BRONX, NY)— A new study led byAlbert Einstein College of Medicine andMontefiore Health System confirms the findings of the large scale British trial of steroid use for COVID-19 patients and advances the research by answering several key questions: Which patients are most likely to benefit from steroid therapy? Could some of them be harmed? Can other formulations of steroids substitute for the agent studied in the British trial? The research was published today in theJournal of Hospital Medicine.
Source: Einstein News - Category: Universities & Medical Training Source Type: news